Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside

Art. -Nr.: HY-W047393: Data Sheet Handling Instructions
FAQs
Technical Support

Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside Chemische Struktur

CAS. Nr. : 64363-77-5

Größe	Verfügbarkeit	Menge
250 mg	Angebot einholen 2 - 3 weeks 1 - 2 weeks 3 - 4 weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
1 g	Angebot einholen 2 - 3 weeks 1 - 2 weeks 3 - 4 weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
5 g	Angebot einholen 2 - 3 weeks 1 - 2 weeks 3 - 4 weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
10 g	Angebot einholen
50 g	Angebot einholen

Synthetic products have potential research and development risk.

or Massenanfrage

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 1 Customer Validation

Spezialitätsempfehlungen

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biologische Aktivität
Reinheit & Dokumentation
Verweise
Kundenbewertung

Beschreibung	Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc^[1].
Molekulargewicht	434.52
Formel	C₂₇H₃₀O₅
CAS. Nr.	64363-77-5
SMILES	COC(O[C@@H]1COCC2=CC=CC=C2)[C@H](OCC3=CC=CC=C3)[C@@H]1OCC4=CC=CC=C4
Versand	Room temperature in continental US; may vary elsewhere.
Speicherung	Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation	Data Sheet (271 KB) Handling Instructions (2659 KB)
Verweise	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [Content Brief]